Crestor Lawsuit

The cholesterol lowering drug Crestor (rosuvastatin) is reported by the consumer group Public Citizen to be implicated in cases of kidney damage and rhabdomyolysis, an adverse reaction involving the destruction of muscle tissue that can lead to kidney failure.  There are numerous drug lawsuits and class action lawsuits currently in place against Vioxx and other drugs.

May 27, 2005 in Cholesterol - Statin, Crestor | Permalink | Comments (0)

Crestor Lawsuit

What are the grounds for a Crestor law suit?
        If you have developed rhabdomyolysis, kidney damage, myoglobinuria, drug-induced hepatitis or a family member has died from acute renal failure (ARF) or any of the above – you will want to file a Crestor law suit. As with all cases of negligence and product liability, you can consult an attorney regarding filing a Crestor law suit, in order to obtain compensation.

December 28, 2004 in Crestor | Permalink | Comments (1)

FDA Chastises AstraZeneca's Crestor Ad

The Food and Drug Administration has criticized an AstraZeneca (AZN:NYSE - news - research) advertisement for making "false or misleading safety claims that minimize the risks" of the cholesterol drug Crestor.

Accusing AstraZeneca of misbranding Crestor, the agency told the company to stop publishing the ad. But the agency's request appears moot: the ad ran for only several days in several major newspapers in late November.

AstraZeneca immediately defended the product, citing clinical trials and comments from higher-ranking FDA officials that the drug is safe. But the company also ran ads to dispel what a spokeswoman said was "a great deal of misinformation."

The ad campaign was immediately attacked by Public Citizen, a consumer group that has petitioned the FDA to ban Crestor, alleging that the drug's side-effect risks outweigh its benefits. Public Citizen petitioned the FDA on Nov. 24 to halt the ads because they were "false and misleading."

The FDA agreed with Public Citizen. In a letter sent to AstraZeneca on Tuesday and published Wednesday on the agency's Web site, the FDA criticized several elements of the ad, including the passage that said, "The FDA has confidence in the safety and efficacy of Crestor."

The agency noted that public comments by top FDA officials include the remark by one that the FDA "has been very concerned about Crestor since the day it was approved, and we've been watching it very carefully."

December 23, 2004 in Crestor, Television | Permalink | Comments (0)

Crestor Lawsuits Loom

A senior official at the US food and drug administration questioned last week whether five drugs, including Crestor, should be on the market. It follows a sustained campaign from consumer group Public Citizen against Crestor.

Crestor's manufacturer - AstraZeneca Plc. - has said it believes the drug is safe.

The FDA on Friday also said that the criticisms made by its drug expert David Graham do not reflect the official views of the agency about Crestor, nor the other four drugs he testified about.

Locally, some doctors and patients say Crestor is a great medication.

Fairfield resident Dave Wilzbach said he started taking Crestor about six months ago after suffering minor side effects from two other cholesterol drugs, Lipitor and Zocor. He had heart surgery three years ago, and doctors want to push his cholesterol level as low as possible, he said.

"I hope they don't ban it. There's probably millions of people out there taking it and not having any trouble," Wilzbach said. "My cholesterol is down from 130 to 105 with no side effects at all. Those other drugs couldn't get my cholesterol that low."

Crestor, considered the most potent of a class of drugs called statins, has become a target of criticism in part because it has been studied in more people than other similar drugs, Roth said. When more people are studied, more problems tend to be detected.

But follow-up studies continue to show that the drug doesn't cause more problems than other statins, he said.

December 22, 2004 in Crestor | Permalink | Comments (1)